← Back to Search

Couples-Based Intervention for HIV Infection (T2 Trial)

N/A
Waitlist Available
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Both partners must have engaged in condomless sex within the past 6 months with any partner
Age 18 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in cr-hiv at 12-month follow-up
Awards & highlights

T2 Trial Summary

This trial will test a couples-based HIV prevention program to see if it can reduce the risk of HIV transmission for transgender women and their partners.

Who is the study for?
This trial is for English-speaking couples aged 18 or older, where one partner is a transgender woman (assigned male at birth but identifies as female) and they've been in an emotional/sexual relationship for over three months. They must have had unprotected sex within the last six months and be able to consent. Couples can't join if either person is currently psychotic, suicidal, manic, or fears physical harm from participating.Check my eligibility
What is being tested?
The study tests a couples-based HIV prevention program against an enhanced standard of care control. It's a large-scale randomized controlled trial involving diverse transgender women and their partners who will be followed quarterly over a year to measure HIV transmission risk through behavior and biomedical indicators like viral suppression and PrEP adherence.See study design
What are the potential side effects?
Since this intervention involves education and behavioral strategies rather than medication, typical drug side effects are not expected. However, participants may experience emotional or psychological discomfort discussing personal topics during sessions.

T2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My partner and I have had unprotected sex in the last 6 months.
Select...
I am 18 years old or older.

T2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes in cr-hiv at 12-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes in cr-hiv at 12-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite Risk for HIV

T2 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants and their partners will complete four couples counseling sessions focused on developing and enhancing relationship skills to decrease HIV risk behaviors.
Group II: ControlActive Control1 Intervention
Participants and their partners will receive information and referrals on HIV risk and prevention strategies.

Find a Location

Who is running the clinical trial?

Brown UniversityOTHER
456 Previous Clinical Trials
562,963 Total Patients Enrolled
Emory UniversityOTHER
1,636 Previous Clinical Trials
2,560,455 Total Patients Enrolled
University of MichiganLead Sponsor
1,795 Previous Clinical Trials
6,373,818 Total Patients Enrolled

Media Library

Couples-based Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04067661 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Intervention, Control
Human Immunodeficiency Virus Infection Clinical Trial 2023: Couples-based Intervention Highlights & Side Effects. Trial Name: NCT04067661 — N/A
Couples-based Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04067661 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate figure of participants in this research project?

"Affirmative. Clinicaltrials.gov attests that this medical experiment, incepted on November 1st 2019 and recently revised on February 28th 2022, is actively recruiting volunteers. The investigators have set their sights on 240 patients from a single site."

Answered by AI

Is the enrollment process for this trial still open?

"Affirmative. According to the clinicaltrials.gov website, this trial is seeking subjects for participation and was initially posted on November 1st 2019 with its most recent edit falling on February 28th 2022. The study requires 240 patients from a single site in order to be successful."

Answered by AI
Recent research and studies
~0 spots leftby Apr 2024